JOHNSON & JOHNSON (JNJ)

Latest Insider Confidence Score

2026Q1

40.1
Bearish

Company insider confidence (by quarter)

2017Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Johnson & Johnson 10% Owner 1,979,173 Apr 10, 2024
Johnson & Johnson Innovation - JJDC, Inc. 10% Owner 1,979,173 Apr 10, 2024
Taubert Jennifer L EVP, WWC. Innovative Medicine 56,471 Sep 5, 2025
Wengel Kathryn E EVP, Chief TO and Risk Officer 42,357.04 Dec 16, 2019
Sneed Michael E EVP, Global Corp Aff & CCO 39,874 Nov 27, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Mar 3, 2026 Decker Robert J VP Corporate Controller Sell 17.5 -4,075 -14.28% ✗ $1M
Feb 20, 2026 Feb 23, 2026 Schmid Timothy Chair Sell 20.0 -1,322 -4.80% ✗ $324.8K
Feb 13, 2026 Feb 18, 2026 Swanson James D. EVP, CIO Sell 15.0 -66,293 -27.95% ✗ $16.1M
Feb 13, 2026 Feb 18, 2026 Wengel Kathryn E EVP, Chief TO and Risk Officer Sell 17.5 -7,266 -1.59% ✗ $1.8M
Feb 13, 2026 Feb 18, 2026 Mulholland Kristen EVP, Chief HR Officer Sell 20.0 -1,585 -2.06% ✗ $387.1K
Feb 13, 2026 Feb 18, 2026 Wolk Joseph J CFO Sell 15.0 -107,784 -23.49% ✗ $26.2M
Feb 13, 2026 Feb 18, 2026 Decker Robert J VP Corporate Controller Sell 20.0 -1,055 -1.13% ✗ $257.8K
Feb 15, 2026 Feb 18, 2026 REED JOHN C EVP, Innovative Medicine, R&D Sell 15.0 -54,844 -47.30% ✗ $13.3M
Feb 13, 2026 Feb 18, 2026 Forminard Elizabeth EVP, Chief Legal Officer Sell 17.5 -8,361 -8.95% ✗ $2M
Feb 13, 2026 Feb 18, 2026 Taubert Jennifer L EVP, WWC. Innovative Medicine Sell 17.5 -15,717 -2.03% ✗ $3.8M
Feb 13, 2026 Feb 18, 2026 Schmid Timothy Chair Sell 16.3 -24,910 -13.84% ✗ $6.1M
Feb 13, 2026 Feb 18, 2026 Duato Joaquin CEO Sell 16.3 -36,230 -2.76% ✗ $8.9M
Feb 13, 2026 Feb 18, 2026 Broadhurst Vanessa EVP, Global Corp Affairs Sell 17.5 -10,611 -7.35% ✗ $2.6M
Feb 9, 2026 Feb 11, 2026 Wolk Joseph J CFO Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Taubert Jennifer L EVP, WWC. Innovative Medicine Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Swanson James D. EVP, CIO Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Schmid Timothy Chair Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Mulholland Kristen EVP, Chief HR Officer Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Forminard Elizabeth EVP, Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Duato Joaquin CEO Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Decker Robert J VP Corporate Controller Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Wengel Kathryn E EVP, Chief TO and Risk Officer Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Broadhurst Vanessa EVP, Global Corp Affairs Neutral 52.5 - 0.00% ✗ -
Feb 6, 2026 Feb 10, 2026 Schmid Timothy Chair Sell 17.5 -10,335 -31.08% ✗ $2.5M
Feb 6, 2026 Feb 9, 2026 Mulholland Kristen EVP, Chief HR Officer Sell 20.0 -3,335 -16.89% ✗ $800.4K
Feb 6, 2026 Feb 9, 2026 Wengel Kathryn E EVP, Chief TO and Risk Officer Sell 16.3 -27,270 -20.41% ✗ $6.5M
Feb 5, 2026 Feb 6, 2026 Forminard Elizabeth EVP, Chief Legal Officer Sell 17.5 -6,226 -28.59% ✗ $1.5M
Aug 23, 2023 Jan 28, 2026 Johnson Paula A Director Neutral 27.5 -11 -11.00% ✗ -
Jan 26, 2026 Jan 28, 2026 Duato Joaquin CEO Sell 15.0 -100,000 -24.52% ✗ $22.1M
Dec 9, 2025 Dec 11, 2025 Woods Eugene A. Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2025 Dec 11, 2025 HEWSON MARILLYN A Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2025 Dec 11, 2025 Pinto Daniel E Director Neutral 52.5 - 0.00% ✗ -
Nov 26, 2025 Dec 1, 2025 MORIKIS JOHN G Director Buy 97.5 +1,250 208.85% ✗ $257.7K
Oct 17, 2025 Oct 20, 2025 REED JOHN C EVP, Innovative Medicine, R&D Sell 17.5 -21,721 -67.08% ✗ $4.2M
Sep 15, 2025 MORIKIS JOHN G Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2025 Sep 11, 2025 HEWSON MARILLYN A Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2025 Sep 11, 2025 Pinto Daniel E Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2025 Sep 11, 2025 Woods Eugene A. Director Neutral 52.5 - 0.00% ✗ -
Sep 4, 2025 Sep 5, 2025 Taubert Jennifer L EVP, WWC. Innovative Medicine Sell 15.0 -56,471 -24.08% ✗ $10M
Aug 29, 2025 Sep 3, 2025 Forminard Elizabeth Executive VP, General Counsel Sell 17.5 -9,570 -42.68% ✗ $1.7M
Aug 22, 2025 Aug 25, 2025 Duato Joaquin CEO Sell 15.0 -125,824 -23.58% ✗ $22.5M
Aug 15, 2025 Aug 18, 2025 Wolk Joseph J CFO Sell 17.5 -16,820 -16.52% ✗ $3M
Jul 17, 2025 Jul 18, 2025 REED JOHN C EVP, Innovative Medicine, R&D Sell 17.5 -19,137 -64.23% ✗ $3.1M
Jul 8, 2025 Pinto Daniel E Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 12, 2025 HEWSON MARILLYN A Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 12, 2025 Woods Eugene A. Director Neutral 52.5 - 0.00% ✗ -
May 1, 2025 May 5, 2025 REED JOHN C EVP, Innovative Medicine, R&D Sell 17.5 -11,002 -26.97% ✗ $1.7M
Apr 24, 2025 Apr 28, 2025 Woods Eugene A. Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 West Nadja Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 WEINBERGER MARK A Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 McClellan Mark B. Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 Joly Hubert Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 Johnson Paula A Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 HEWSON MARILLYN A Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 Beckerle Mary C Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2025 Apr 28, 2025 Doudna Jennifer A Director Neutral 52.5 - 0.00% ✗ -
Mar 18, 2025 Mar 19, 2025 Duato Joaquin CEO Neutral 52.5 - 0.00% ✗ -
Mar 4, 2025 Mar 6, 2025 HEWSON MARILLYN A Director Neutral 52.5 - 0.00% ✗ -
Mar 4, 2025 Mar 6, 2025 Woods Eugene A. Director Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 Feb 28, 2025 Woods Eugene A. Director Buy 91.3 +100 66.67% ✗ $14.6K
Feb 25, 2025 Feb 26, 2025 Decker Robert J VP Corporate Controller Sell 17.5 -6,999 -24.34% ✗ $1.2M
Feb 15, 2025 Feb 19, 2025 Wolk Joseph J CFO Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Wengel Kathryn E EVP, Chief TO and Risk Officer Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Taubert Jennifer L EVP, WWC. Innovative Medicine Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Swanson James D. EVP, CIO Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Schmid Timothy Chair Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 REED JOHN C EVP, Innovative Medicine, R&D Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Mulholland Kristen EVP, Chief HR Officer Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Forminard Elizabeth Executive VP, General Counsel Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Decker Robert J VP Corporate Controller Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Duato Joaquin CEO Neutral 52.5 - 0.00% ✗ -
Feb 15, 2025 Feb 19, 2025 Broadhurst Vanessa EVP, Global Corp Affairs Neutral 52.5 - 0.00% ✗ -
Feb 14, 2025 Feb 18, 2025 Schmid Timothy Chair Sell 22.5 -1,015 -5.44% ✗ $159.1K
Feb 13, 2025 Feb 18, 2025 Schmid Timothy Chair Sell 22.5 -1,235 -2.80% ✗ $193K
Feb 13, 2025 Feb 18, 2025 Wengel Kathryn E EVP, Chief TO and Risk Officer Sell 30.0 -3,296 -0.89% ✗ $516.1K
Feb 13, 2025 Feb 18, 2025 Wolk Joseph J CFO Sell 17.5 -9,080 -8.67% ✗ $1.4M
Feb 15, 2025 Feb 18, 2025 REED JOHN C EVP, Innovative Medicine, R&D Sell 22.5 -385 -2.42% ✗ $60.1K
Feb 13, 2025 Feb 18, 2025 Taubert Jennifer L EVP, WWC. Innovative Medicine Sell 17.5 -10,320 -1.48% ✗ $1.6M
Feb 13, 2025 Feb 18, 2025 Swanson James D. EVP, CIO Sell 20.0 -1,740 -2.55% ✗ $272.4K
Feb 13, 2025 Feb 18, 2025 Mulholland Kristen EVP, Chief HR Officer Sell 22.5 -1,008 -1.91% ✗ $157.7K
Feb 13, 2025 Feb 18, 2025 Forminard Elizabeth Executive VP, General Counsel Sell 22.5 -1,253 -3.11% ✗ $195.9K
Feb 13, 2025 Feb 18, 2025 Duato Joaquin CEO Sell 27.5 -13,696 -0.85% ✗ $2.1M
Feb 13, 2025 Feb 18, 2025 Decker Robert J VP Corporate Controller Sell 22.5 -824 -1.01% ✗ $128.9K
Feb 13, 2025 Feb 18, 2025 Broadhurst Vanessa EVP, Global Corp Affairs Sell 20.0 -1,880 -2.12% ✗ $294.3K
Feb 10, 2025 Feb 12, 2025 Decker Robert J VP Corporate Controller Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Forminard Elizabeth Executive VP, General Counsel Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Wolk Joseph J CFO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Wengel Kathryn E EVP, Chief TO and Risk Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Mulholland Kristen EVP, Chief HR Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Taubert Jennifer L EVP, WWC. Innovative Medicine Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Schmid Timothy Chair Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Swanson James D. EVP, CIO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Duato Joaquin CEO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Broadhurst Vanessa EVP, Global Corp Affairs Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 11, 2025 Duato Joaquin CEO Sell 15.0 -100,643 -20.51% ✗ $15.4M
Feb 7, 2025 Feb 11, 2025 Wengel Kathryn E EVP, Chief TO and Risk Officer Sell 17.5 -26,076 -22.60% ✗ $4M
Feb 7, 2025 Feb 11, 2025 Taubert Jennifer L EVP, WWC. Innovative Medicine Sell 16.3 -47,436 -22.23% ✗ $7.3M
Feb 7, 2025 Feb 11, 2025 Wolk Joseph J CFO Sell 17.5 -13,015 -15.50% ✗ $2M
Dec 12, 2024 Dec 12, 2024 WEINBERGER MARK A Director Buy 95.0 +1,000 100.00% ✗ $147.2K
Dec 10, 2024 Dec 12, 2024 Woods Eugene A. Director Neutral 52.5 - 0.00% ✗ -